China's Ausia BioTech seeks international pharma customers
Hangzhou CMO Ausia BioTech has partnered with New Mexico-based PaizaBio to market its manufacturing services to Western drugmakers interested in the Chinese sterile injectables market.
Archives for September 22, 2015
Pfizer to sell Mumbai manufacturing plant for $27m
Pfizer has agreed to sell a manufacturing facility in India to Vidhi Research and Development for around $27m.
A reliable supply chain has never been more important, says Mylan CEO
Drugmakers need more certainty and reliabilty around their supply chain in light of increased regulatory vigilance says Mylan, itself carrying out remediation across several Indian facilities.
Vaccine-maker IDT Biologika launches in US
German CDMO IDT Biologika has opened its first facility in the US and will contract manufacture vaccines.
Aesica and Merck & Co. to benefit from green energy cost-savings in UK
Electricity from a ‘green energy’ biomass plant being built nearby will cut utility costs at an Aesica UK facility and help the CDMO stay competitive.
Study authors urge IRBs to reject trials that deny babies pain relief
Researchers are urging review boards to reject neonatal clinical trials if protocols require that babies in control groups are denied analgesia.
EC, EU and WHO share 'need to know' private drug data
European regulators and the WHO have begun sharing confidential information about drug applications, quality, and inspections under a new agreement.
India mulls reclassifying vitamins as drugs if they come with health claims
India may classify vitamin supplements as drugs rather than foods if the manufacturers of such products claim they can treat or prevent disease.